| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -21,132 | -29,843 |
| Stock-based compensation expense | 11,604 | 8,969 |
| Depreciation | 16,633 | 11,165 |
| Change in operating lease right-of-use assets | -5 | -25 |
| Amortization of purchased intangible assets and finance leases | 577 | 411 |
| Amortization of debt issuance costs and accretion of debt discount | 5,568 | 3,727 |
| Impairment of goodwill | 0 | 0 |
| Impairment of intangibles and other assets | 0 | 0 |
| Gain on troubled debt restructuring | 42,429 | - |
| Gain on debt extinguishment | 0 | 0 |
| Gain on change in fair value of warrants | -8,758 | -5,825 |
| Interest expense | 13,750 | 7,653 |
| (reversal of) allowance for credit losses | -494 | -185 |
| Gain on disposition of business | 0 | 0 |
| Deferred income taxes | 228 | 165 |
| Accounts receivable | -10,228 | -5,720 |
| Prepaid expenses and other assets | -1,489 | 25,345 |
| Contract acquisition costs | -7,070 | -4,175 |
| Accounts payable, accrued expenses and other current liabilities | -12,420 | 6,399 |
| Deferred revenue | -2,819 | -2,136 |
| Other liabilities | 129 | 203 |
| Net cash used in operating activities | -20,781 | -14,772 |
| Purchases of property and equipment, including internal-use software | 9,784 | 6,895 |
| Purchases of intangible assets | 1,431 | 1,052 |
| Net cash used in investing activities | -11,215 | -7,947 |
| Proceeds from issuance of common stock in connection with the exercise of options and espp | 471 | 471 |
| Principal payments for finance leases | 26 | 27 |
| Payment on settlement of warrants | 1,297 | - |
| Payment in connection with troubled debt restructuring | 45,000 | - |
| Proceeds from issuance of senior notes | 0 | 0 |
| Payment of debt issuance costs | 0 | 0 |
| Repayments of convertible debt-Convertible Senior Notes Due2024 | 0 | 0 |
| Repayments of convertible debt-Convertible Senior Notes Due2026 | 0 | 0 |
| Net cash used in financing activities | -45,852 | 444 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1,272 | 1,001 |
| Net decrease in cash and cash equivalents | -76,576 | -21,274 |
| Cash and cash equivalents at beginning of period | 183,237 | - |
| Cash and cash equivalents at end of period | 106,661 | - |
LIVEPERSON INC (LPSN)
LIVEPERSON INC (LPSN)